Bioorthogonal Reaction-Mediated Enzymatic Elongation-Driven Dendritic Nanoassembly for Genome-Wide Analysis of 5-Hydroxymethyluracil in Breast Tissues
Source abstract
Abstract
5-Hydroxymethyluracil (5hmU) is an oxidation derivative of thymine in the genomes of various organisms and may serve as both an epigenetic mark and a cancer biomarker. However, the current 5hmU assays usually have drawbacks of laborious procedures, low specificity, and unsatisfactory sensitivity. Herein, we demonstrate the click chemistry-mediated hyperbranched amplification-driven dendritic nanoassembly for genome-wide analysis of 5hmU in breast cell lines and human breast tissues. The proposed strategy possesses good selectivity, ultralow background, and high sensitivity with a detection limit of 83.28 aM. This method can accurately detect even a 0.001% 5hmU level in the mixture. Moreover, it can determine 5hmU at single-cell level and distinguish the expressions of 5hmU in tissues of normal persons and breast cancer patients, holding great promise in 5hmU-related biological research and clinical diagnosis.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Epigenetics and DNA Methylation · Advanced biosensing and bioanalysis techniques · Genomics and Chromatin Dynamics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Chemistry, Chemical Engineering and Materials Science, Shandong Normal University, Jinan 250014, China
Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California 92093, United States
School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
Funding
National Natural Science Foundation of China
References (36)
Show source-provided references
1. 10.1038/s41570-018-0044-410.1038/s41570-018-0044-4 ↗
2. 10.1038/nchem.211510.1038/nchem.2115 ↗
3. 10.1126/science.117011610.1126/science.1170116 ↗
4. 10.1021/acs.nanolett.7b0391110.1021/acs.nanolett.7b03911 ↗
5. 10.1038/nchembio.15310.1038/nchembio.153 ↗
6. 10.1093/nar/gkv119910.1093/nar/gkv1199 ↗
7. 10.1016/j.cell.2011.06.02010.1016/j.cell.2011.06.020 ↗
8. 10.1038/nchembio.153210.1038/nchembio.1532 ↗
9. 10.1186/s12967-018-1581-910.1186/s12967-018-1581-9 ↗
10. 10.1016/j.mrrev.2016.02.00110.1016/j.mrrev.2016.02.001 ↗
11. 10.1002/anie.20180404610.1002/anie.201804046 ↗
12. 10.1039/D1SC03812E10.1039/D1SC03812E ↗
13. 10.3390/molecules2805211610.3390/molecules28052116 ↗
14. 10.1021/jacs.9b1139310.1021/jacs.9b11393 ↗
15. Frenkel K. · Cancer Epidemiol. Biomarkers Prev. · 1998 · 7 · 49
16. 10.1021/acs.analchem.1c0128510.1021/acs.analchem.1c01285 ↗
17. 10.1016/j.cell.2011.03.02210.1016/j.cell.2011.03.022 ↗
18. 10.1093/biomethods/bpw00610.1093/biomethods/bpw006 ↗
19. 10.1016/j.toxlet.2004.11.00910.1016/j.toxlet.2004.11.009 ↗
20. 10.1016/j.clim.2022.10899710.1016/j.clim.2022.108997 ↗
21. 10.1186/s13059-017-1150-110.1186/s13059-017-1150-1 ↗
22. 10.1021/ac201057w10.1021/ac201057w ↗
23. 10.1021/tx700221x10.1021/tx700221x ↗
24. 10.1021/acs.analchem.6b0290010.1021/acs.analchem.6b02900 ↗
25. 10.1016/j.cclet.2019.02.00510.1016/j.cclet.2019.02.005 ↗
26. 10.1021/acs.analchem.0c0541910.1021/acs.analchem.0c05419 ↗
27. 10.1021/acs.nanolett.0c0513710.1021/acs.nanolett.0c05137 ↗
28. 10.1016/j.ymeth.2014.11.00710.1016/j.ymeth.2014.11.007 ↗
29. 10.1021/acs.accounts.6b0023710.1021/acs.accounts.6b00237 ↗
30. 10.1021/nl080093z10.1021/nl080093z ↗
31. 10.1021/acs.chemrev.0c0079910.1021/acs.chemrev.0c00799 ↗
32. 10.7150/thno.1485610.7150/thno.14856 ↗
33. 10.1021/acs.nanolett.9b0426710.1021/acs.nanolett.9b04267 ↗
34. 10.1021/acs.nanolett.1c0132810.1021/acs.nanolett.1c01328 ↗
35. 10.1016/j.freeradbiomed.2016.10.53510.1016/j.freeradbiomed.2016.10.535 ↗
36. 10.1021/acs.analchem.7b0349010.1021/acs.analchem.7b03490 ↗